TY - JOUR
T1 - Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients with Left Ventricular Systolic Dysfunction
AU - Khan, Mahin R.
AU - Kayani, Waleed T.
AU - Pelton, Jason
AU - Ansari, Ahmed
AU - Paniagua, David
AU - Khalid, Umair
AU - Denktas, Ali
AU - Changezi, Hameem U.
AU - Munir, Ahmad
AU - Jimenez, Ernesto
AU - Alam, Mahboob
AU - Jneid, Hani
N1 - Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2021/6
Y1 - 2021/6
N2 - Purpose: There is a paucity of comparative data examining the optimal revascularization strategy in patients with left ventricular systolic dysfunction (LVD). Methods: We performed an aggregate data meta-analysis of clinical outcomes comparing percutaneous coronary intervention (PCI) versus coronary artery bypass (CABG) in patients with LVD (left ventricle ejection fraction (LVEF) of ≤ 40%), using the random effects model. Effects size is reported as odds ratio (OR) and a 95% confidence interval. Outcomes included all-cause mortality, myocardial infarction, stroke, repeat revascularization, and a composite of major adverse cardiac and cerebrovascular events (MACCE) at 30-day, 3-year, and long-term (6.3 ± 0.9 years) follow-ups. Seventeen studies (16 observational, 1 randomized) and 18,599 patients (CABG 9651; PCI 8948) were included. Results: PCI and CABG had comparable all-cause mortality at 30 days (OR 0.78, 95% CI 0.49–1.23) and 3 years (OR 1.05, 95% CI 0.91–1.21); however, PCI was associated with increased long-term morality after a mean follow-up of 6.3 ± 0.9 years (31.6% vs. 24.3%, OR 1.41, 95% CI 1.21–1.64). A similar mortality trend was observed in the subgroup of patients with EF ≤ 35%. PCI had a higher rate of repeat revascularization at 3-year and long-term follow-ups. The long-term rates of stroke and MI were comparable. PCI, on the other hand, had lower rates of stroke at 30-day and 3-year follow-ups. Conclusion: CABG was associated with lower rates of long-term mortality and revascularization but higher rate of upfront stroke in patients with LVD. However, the data included consisted predominantly of observational studies, highlighting the paucity and need for randomized trials.
AB - Purpose: There is a paucity of comparative data examining the optimal revascularization strategy in patients with left ventricular systolic dysfunction (LVD). Methods: We performed an aggregate data meta-analysis of clinical outcomes comparing percutaneous coronary intervention (PCI) versus coronary artery bypass (CABG) in patients with LVD (left ventricle ejection fraction (LVEF) of ≤ 40%), using the random effects model. Effects size is reported as odds ratio (OR) and a 95% confidence interval. Outcomes included all-cause mortality, myocardial infarction, stroke, repeat revascularization, and a composite of major adverse cardiac and cerebrovascular events (MACCE) at 30-day, 3-year, and long-term (6.3 ± 0.9 years) follow-ups. Seventeen studies (16 observational, 1 randomized) and 18,599 patients (CABG 9651; PCI 8948) were included. Results: PCI and CABG had comparable all-cause mortality at 30 days (OR 0.78, 95% CI 0.49–1.23) and 3 years (OR 1.05, 95% CI 0.91–1.21); however, PCI was associated with increased long-term morality after a mean follow-up of 6.3 ± 0.9 years (31.6% vs. 24.3%, OR 1.41, 95% CI 1.21–1.64). A similar mortality trend was observed in the subgroup of patients with EF ≤ 35%. PCI had a higher rate of repeat revascularization at 3-year and long-term follow-ups. The long-term rates of stroke and MI were comparable. PCI, on the other hand, had lower rates of stroke at 30-day and 3-year follow-ups. Conclusion: CABG was associated with lower rates of long-term mortality and revascularization but higher rate of upfront stroke in patients with LVD. However, the data included consisted predominantly of observational studies, highlighting the paucity and need for randomized trials.
KW - Cardiomyopathy
KW - Coronary artery bypass
KW - Ejection fraction
KW - Left ventricular systolic dysfunction
KW - Percutaneous coronary intervention
KW - Revascularization
UR - http://www.scopus.com/inward/record.url?scp=85090437321&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090437321&partnerID=8YFLogxK
U2 - 10.1007/s10557-020-07063-0
DO - 10.1007/s10557-020-07063-0
M3 - Review article
C2 - 32902738
AN - SCOPUS:85090437321
SN - 0920-3206
VL - 35
SP - 575
EP - 585
JO - Cardiovascular Drugs and Therapy
JF - Cardiovascular Drugs and Therapy
IS - 3
ER -